A study published in Pharmacotherapy on November 19, 2022, challenges the long-held notion that renal function should be adjusted based on race.

Corey Diamond, PharmD

On October 26, 2017, the opioid crisis was officially declared a public health emergency in the United States. Since then, opioid overdoses have failed to decline—CDC’s 2020 data on opioid overdoses demonstrated a 31% increase over 2019.

Ariel Clark, PharmD

Olunife Akinmolayan, APhA–ASP National Member-at-large, and 2023 PharmD candidate, University of Findlay, Findlay, OH

Jason S. Haney, PharmD, BCPS, BCCCP

Every at-home COVID-19 test that leaves Moose Pharmacy in Charlotte, NC, carries a sticker bearing a QR code. Beside the code, the text reads, “Test POSITIVE for COVID-19?" 

A new study published in JAMA investigated how various treatment interventions affected long-term outcomes in critically ill patients with COVID-19.

Olivia C. Welter, PharmD

Hydroxychloroquine and the risk for incident retinopathy.

News roundup

Since the onset of the COVID-19 pandemic, pharmacists’ scope of practice has expanded exponentially, with pharmacists on the front lines administering COVID-19 vaccines and offering COVID-19 testing services.

Kristin Wiisanen, PharmD, FAPhA, FCCP

Springtime, blue skies, and this year’s Annual Meeting & Exposition are here, and with them the promise of new growth, expansion, and an invitation to open one’s arms to welcome change.

Ilisa BG Bernstein, PharmD, JD, FAPhA